Drug therapies for sustained release include estrogen microparticles and progesterone used in hormone replacement therapy for female mammals, as well as a surfactant, an isomerizer, a sticker and one or more preservatives.
<；p>； Parenteral pharmaceutical formulation in sustained release suspension containing suspended particles of estradiol and progesterone, a surfactant, an isosmoacute； agent, a viscous agent and a conservative one or maacute； s , useful as a hormone replacement therapy. <；/p>；<；p>；Formulació；n farmacé；utica parenteral en suspensió；n de liberació；n sostenida que contiene partí；culas suspendidas de estradiol y progesterona, un agente tensoactivo, un agente isosmó；tico, un agente viscosante y uno o má；s conservadores, ú；til como terapia de reemplazo hormonal.<；/p>；
